PUBLISHER: The Business Research Company | PRODUCT CODE: 1946565
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946565
Molecular diagnostics devices are utilized for the diagnosis of infectious diseases and screening by detecting specific sequences in DNA or RNA. These devices aid in providing more accurate therapeutic interventions, especially in the early stages of a disease.
The main products of molecular diagnostics devices include instruments, reagents, and consumables. Reagents, in this context, refer to substances used to cause a chemical reaction, often employed to indicate the presence of another substance. Various technologies are involved in molecular diagnostics, such as DNA (deoxyribonucleic acid) sequencing, polymerase chain reaction, isothermal nucleic acid amplification technology, transcription-mediated amplification (TMA), in situ hybridization, microarrays, mass spectrometry, and others such as southern blotting, northern blotting, and electrophoresis. These technologies find applications in cancer diagnosis, pharmacogenomics, genetic testing, infectious disease detection, prenatal screening, neurological disease analysis, and cardiovascular disease assessment. Molecular diagnostics devices are used by various end-users, including diagnostic laboratories, hospitals, and others such as nursing homes, blood banks, and point-of-care facilities.
Tariffs are influencing the molecular diagnostics devices and equipment market by increasing costs of imported PCR machines, sequencing instruments, reagents, enzymes, and software-enabled hardware components. Diagnostic laboratories and hospitals in North America and Europe are significantly affected due to dependence on imported high-precision equipment, while Asia-Pacific faces cost pressures on reagent exports. These tariffs are raising testing costs and slowing system upgrades. At the same time, they are supporting local manufacturing, regional reagent production, and increased innovation in cost-efficient molecular diagnostic platforms.
The molecular diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides molecular diagnostics devices and equipment market statistics, including molecular diagnostics devices and equipment industry global market size, regional shares, competitors with a molecular diagnostics devices and equipment market share, detailed molecular diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics devices and equipment industry. This molecular diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The molecular diagnostics devices and equipment market size has grown rapidly in recent years. It will grow from $27.23 billion in 2025 to $30.33 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to growth in infectious disease testing, expansion of genetic screening programs, rising use of molecular diagnostics in oncology, improvements in sequencing accuracy, increased clinical awareness of molecular testing.
The molecular diagnostics devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising investments in genomic diagnostics, expansion of decentralized molecular testing, growing adoption of automated sample processing, increasing focus on early-stage disease detection. Major trends in the forecast period include increasing adoption of pcr-based testing platforms, rising use of next-generation sequencing technologies, growing integration of diagnostic software and bioinformatics, expansion of companion diagnostics applications, enhanced focus on early and personalized diagnosis.
The increasing incidence of infectious diseases is expected to drive the growth of the molecular diagnostic devices and equipment market in the future. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals or from animals to humans. Factors contributing to the rise in infectious diseases include antimicrobial resistance, globalization and travel, urbanization, socioeconomic disparities, and an aging population. Molecular diagnostic devices and equipment are critical tools for the detection and management of these diseases. For example, in March 2023, the Office for National Statistics, a UK government department, reported that during the week ending March 17, 2023, the UK recorded 619 deaths related to COVID-19, an increase from 605 the previous week. During that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, a slight decrease from 4.6% the week before. Thus, the rising incidence of infectious diseases is propelling the growth of the molecular diagnostic devices and equipment market.
Major companies in the molecular diagnostics devices and equipment market are innovating by developing products such as high-throughput sample-to-result instruments for molecular diagnostics. ELITechGroup, for instance, launched a high-throughput sample-to-result instrument in April 2023, based on its proven extraction and assay technology. The instrument allows continuous loading of samples and reagents with real random-access capability, providing users with the flexibility to run different PCR reagents, protocols, and sample matrices in parallel.
In February 2023, Sherlock Biosciences, a US-based synthetic biology firm, acquired Sense Bio-detection for an undisclosed sum. With this acquisition, Sherlock intends to enhance its CRISPR-based molecular diagnostics capabilities by incorporating Sense Bio-detection's Veros instrument-free rapid test platform and manufacturing expertise. Sense Bio-detection is a UK-based molecular diagnostics company offering single-use molecular testing devices.
Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomerieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the molecular diagnostics devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The molecular diagnostics devices and equipment market consist of sales of thermocycler, single particle mass spectrometers, time-of-flight mass spectrometer (TOF) and others that are used to detect pathogen and infectious diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. This market is segmented into instruments, reagents, and consumables.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Molecular Diagnostics Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses molecular diagnostics devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for molecular diagnostics devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular diagnostics devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.